Corliber
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $7.8M
Investors
- 1
About Corliber
Established in 2016 and based in Guangdong, China, Corliber is a biotechnology company engaged in the development of new biomedical materials and orthopedic implanted medical devices.D. in medical field. Corliber researches and develops high-purity lactide monomer preparation technology, high-purity ultra-high molecular weight medical grade polylactic acid (PLA) synthesis technology and other composite medical raw material preparation technology. The company has patents for materials such as hydroxyapatite (HA) core-shell structure modification and nano-level HA dispersion composite materials. In the future, Corliber will continue to advance new pipelines such as Corliber Oral Artificial Bone and suspension plates, metal anchors, and fillable and biodegradable medical beauty products. In terms of new product development, the company plans to accelerate the progress of obtaining evidence for artificial bone and absorbable interface screws, and actively engage in more academic research and develop market-oriented sales channels.
Who invested in Corliber
1 investor across 1 round
See all investors in Corliber
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 17, 2021
Amount
$7.8M
Investors
Questions about Corliber
Who invested in Corliber?
Corliber has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Corliber raised?
Corliber has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Corliber last raise money?
Corliber's most recent round on record is a Series A, in Jun 2021.
What does Corliber do?
Established in 2016 and based in Guangdong, China, Corliber is a biotechnology company engaged in the development of new biomedical materials and orthopedic implanted medical devices.
Where is Corliber headquartered?
Corliber is headquartered in Shenzhen, China.
Which VCs invest in companies like Corliber?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Corliber's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Corliber? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.